Navigation Links
Mylan Receives Approval for Generic Version of Arimidex® Tablets
Date:6/29/2010

PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1 mg, the generic version of AstraZeneca's Arimidex® Tablets, a treatment for early breast cancer.

Anastrozole Tablets had U.S. sales of approximately $917 million for the 12 months ending March 31, 2010, according to IMS Health. The product is available for immediate shipment.

Currently, Mylan has 136 ANDAs pending FDA approval representing $94 billion in annual brand sales, according to IMS Health. Forty-one of these pending ANDAs are potential first-to-file opportunities, representing $20.4 billion in annual brand sales, for the 12 months ending Dec. 31, 2009 according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Zocor® Tablets
2. Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets
3. Mylan Receives Approval for Generic Version of Neurontin® Tablets
4. Mylan Receives Approval for Generic Version of Valtrex®
5. Mylan Launches Temazepam Capsules USP, 7.5 mg
6. Mylan Announces Completion of Senior Notes Offering
7. Mylan Announces Upsizing and Pricing of Senior Notes
8. Mylan Announces Proposed Senior Notes Private Placement
9. Mylan Receives Approval for Generic Version of Zyban(R)
10. Mylan Receives Approval for Generic Version of Flomax(R)
11. Mylan Schedules First Quarter 2010 Financial Results Conference Call and Live Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Research Corp., also known as ,The Epigenetics Company, announced today the release ... manner using the myDNAge ™ test. Based on Horvath,s Clock, so ... and biostatistics at the David Geffen School of Medicine at UCLA ... DNAge ™ technology is used to analyze DNA methylation patterns of ... ...
(Date:7/11/2017)...  Sysmex America, Inc., a leading provider of ... well as middleware information systems technology, today announced ... assurance easier and more risk free than manual ... the innovation that it delivers to the laboratory. ... processes to a new level with automated, continuous ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment ... in 2021, according to Medical Equipment & ... by Freedonia Focus Reports. Continued increases in demand for ... aging of the population and supported by gains in ... equipment and supplies. New product introductions will also drive ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... CA (PRWEB) , ... July 27, 2017 , ... ... the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to its ... accelerated diagnostics and sleep care management. The speed and functionality of scoring in ...
(Date:7/27/2017)... ... ... isn’t always easy. Currently, more than 80 percent of Americans fail to eat the recommended ... sugar. This trend may help explain why the obesity rate seems stuck. The most recent ... culture, we seem to have food on the brain more. "We eat two more large ...
(Date:7/27/2017)... ... 27, 2017 , ... HIMSS announced today that Michael Daniel, ... the HIMSS Healthcare Security Forum, the nation’s foremost event for health organizations tackling ... 2017. , Daniel will deliver his keynote, The Evolving Healthcare Information Security Organization, ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... Talent Management Solutions as part of their continued efforts to provide innovative offerings ... develop the best IT resources and build dynamic, high-performing teams to address healthcare ...
Breaking Medicine News(10 mins):